Zentalis Pharmaceuticals, Inc. Common Stock ZNTL

$3.88 -0.26% at last close

Recent SEC Filings

FormDescriptionFiledDocument
4 Insider transaction 2026-08-19 View →
8-K 8-K 2026-08-14 View →
424B5 424B5 2026-08-14 View →
424B5 424B5 2026-08-13 View →
10-Q 10-Q 2026-08-06 View →
8-K 8-K 2026-08-06 View →
4 FORM 4 2026-06-18 View →
4 FORM 4 2026-06-18 View →
4 FORM 4 2026-06-18 View →
4 FORM 4 2026-06-18 View →
4 FORM 4 2026-06-18 View →
8-K 8-K 2026-06-18 View →
4 FORM 4 2026-05-27 View →
8-K 8-K 2026-05-27 View →
8-K 8-K 2026-05-21 View →
10-Q 10-Q 2026-05-12 View →
8-K 8-K 2026-05-12 View →
8-K 8-K 2026-05-05 View →
DEF 14A DEF 14A 2026-04-30 View →
8-K 8-K 2026-04-17 View →
8-K 8-K 2026-04-09 View →
10-K 10-K 2026-03-26 View →
8-K 8-K 2026-03-26 View →
4 FORM 4 2026-02-10 View →
4 FORM 4 2026-02-10 View →
4 FORM 4 2026-02-10 View →
4 FORM 4 2026-02-04 View →
4 FORM 4 2026-01-09 View →
4 FORM 4 2026-01-09 View →
4 FORM 4 2026-01-09 View →
4 FORM 4 2026-01-09 View →
8-K 8-K 2026-01-09 View →
4 Insider transaction 2026-01-08 View →
4 Insider transaction 2025-12-15 View →
8-K 8-K 2025-12-15 View →
10-Q 10-Q 2025-11-10 View →
8-K 8-K 2025-11-10 View →
4 FORM 4 2025-10-01 View →
8-K 8-K 2025-08-26 View →
10-Q 10-Q 2025-08-06 View →

Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.

Key Stats

Last Close
$3.88
Market Cap
$367.33 million
52-Week Range
$1.21 – $6.95
Average Volume
1.24 million shs

Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.